DP-155

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameDP-155
Drug Alias NameIndometacin phospholipid derivative
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsAlzheimer DiseaseColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesD-Pharm Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesD-Pharm Ltd
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseaseColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A